Cardiff Oncology, Inc.

Cardiff Oncology, Inc. financial statements

Cardiff Oncology, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 593K10-K
Net income−USD 45.85M10-K
Cash and equivalentsUSD 17.47M10-Q
Total debtUSD 832KEODHD

Cardiff Oncology, Inc. financials on 6ix · Cardiff Oncology, Inc. on 6ix